REXVIQUE
Live / Registered — Registered (as of 24 Jan 2023)
What this means for you
Registered since 24 Jan 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97052212
- Registration number
- 6960646
- Mark type
- Stylized text
- Filed
- 29 Sept 2021
- Published for opposition
- 08 Nov 2022
- Registered
- 24 Jan 2023
- Attorney of record
- Christopher M. Hanes
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- GlaxoSmithKline Biologicals SA, Rixensart, BE
- GlaxoSmithKline Biologicals SA, Rixensart, BE
- GlaxoSmithKline Biologicals SA, Rixensart, BE
Prosecution history
- 24 Jan 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 Jan 2023 — REGISTERED-PRINCIPAL REGISTER
- 08 Nov 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Nov 2022 — PUBLISHED FOR OPPOSITION
- 19 Oct 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Oct 2022 — ELECTRONIC RECORD REVIEW COMPLETE
- 30 Sept 2022 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 12 Sept 2022 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 12 Sept 2022 — PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
- 30 Aug 2022 — WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
- 29 Aug 2022 — ASSIGNED TO PETITION STAFF
- 11 Aug 2022 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 09 Aug 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Aug 2022 — PUBLISHED FOR OPPOSITION
- 03 Aug 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED